Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers
- 20 March 2000
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 294 (1-2), 157-168
- https://doi.org/10.1016/s0009-8981(00)00182-0
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Hepatitis CThe Lancet, 1998
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997
- Hepatitis C and hepatocellular carcinomaHepatology, 1997
- The long-term pathological evolution of chronic hepatitis CHepatology, 1996
- Prevalence of chronic liver disease in the general population of northern Italy: The dionysos studyHepatology, 1994
- Hepatitis C virus six years onThe Lancet, 1994
- Long-term follow-up of chronic hepatitis B patients treated with interferon alfaGastroenterology, 1993
- Molecular virology and pathogenesis of hepatitis BThe Lancet, 1993
- Interferon alfa therapy in patients with chronic hepatitis B virus infectionGastroenterology, 1991
- Matrix Degradation in the LiverSeminars in Liver Disease, 1990